Elevance Health Inc (0HG8.L)

Healthcare | Medical Equipment Services
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 50,711,000,000 49,776,000,000 48,891,000,000 45,442,000,000
Cost of Revenue 43,520,000,000 0 0 0
Gross Profit 7,191,000,000 49,776,000,000 48,891,000,000 45,442,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 0 0 0 0
Operating Expenses 5,434,000,000 47,484,000,000 46,094,000,000 44,836,000,000
Operating Income 1,757,000,000 2,292,000,000 2,797,000,000 606,000,000
Interest Expense 351,000,000 341,000,000 344,000,000 340,000,000
Income Before Tax 1,406,000,000 2,292,000,000 2,797,000,000 606,000,000
Income Tax Expense 219,000,000 548,000,000 613,000,000 193,000,000
Net Income 1,189,000,000 1,743,000,000 2,183,000,000 418,000,000
Per Share
EPS 5.32 7.72 9.64 1.84
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 176,810,000,000 171,340,000,000 156,595,000,000
Cost of Revenue 0 124,330,000,000 -4,000,000
Gross Profit 176,810,000,000 47,010,000,000 156,599,000,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 0 0 30,682,000,000
Operating Expenses 168,906,000,000 38,265,000,000 31,502,000,000
Operating Income 7,904,000,000 8,745,000,000 8,663,000,000
Interest Expense 1,185,000,000 1,030,000,000 851,000,000
Income Before Tax 7,904,000,000 7,715,000,000 7,600,000,000
Income Tax Expense 1,933,000,000 1,724,000,000 1,712,000,000
Net Income 5,980,000,000 5,987,000,000 5,894,000,000
Per Share
EPS 25.81 25.69 24.56
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 8,288,000,000 6,526,000,000 7,387,000,000
Short Term Investments 25,201,000,000 29,614,000,000 26,905,000,000
Net Receivables 19,071,000,000 17,865,000,000 0
Inventory 0 0 0
Total Current Assets 52,560,000,000 54,005,000,000 55,617,000,000
Property Plant Equipment 5,219,000,000 4,359,000,000 4,920,000,000
Goodwill and Intangibles 40,371,000,000 35,590,000,000 34,698,000,000
Total Assets 116,889,000,000 108,928,000,000 102,755,000,000
Liabilities
Account Payables 22,673,000,000 23,021,000,000 5,607,000,000
Short Term Debt 2,014,000,000 1,874,000,000 1,946,000,000
Total Current Liabilities 26,195,000,000 26,297,000,000 39,696,000,000
Long Term Debt 29,218,000,000 23,246,000,000 22,349,000,000
Total Liabilities 75,463,000,000 69,523,000,000 66,425,000,000
Shareholders Equity
Retained Earnings 33,549,000,000 31,749,000,000 29,647,000,000
Total Shareholders Equity 41,315,000,000 39,306,000,000 36,243,000,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 8,288,000,000 6,526,000,000 7,387,000,000
Short Term Investments 25,201,000,000 29,614,000,000 26,905,000,000
Net Receivables 19,071,000,000 17,865,000,000 0
Inventory 0 0 0
Total Current Assets 52,560,000,000 54,005,000,000 55,617,000,000
Property Plant Equipment 5,219,000,000 4,359,000,000 4,920,000,000
Goodwill and Intangibles 40,371,000,000 35,590,000,000 34,698,000,000
Total Assets 116,889,000,000 108,928,000,000 102,755,000,000
Liabilities
Account Payables 22,673,000,000 23,021,000,000 5,607,000,000
Short Term Debt 2,014,000,000 1,874,000,000 1,946,000,000
Total Current Liabilities 26,195,000,000 26,297,000,000 39,696,000,000
Long Term Debt 29,218,000,000 23,246,000,000 22,349,000,000
Total Liabilities 75,463,000,000 69,523,000,000 66,425,000,000
Shareholders Equity
Retained Earnings 33,549,000,000 31,749,000,000 29,647,000,000
Total Shareholders Equity 41,315,000,000 39,306,000,000 36,243,000,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 5,971,000,000 5,987,000,000 5,894,000,000
Depreciation & Amortization 1,393,000,000 1,745,000,000 1,675,000,000
Stock Based Compensation 191,000,000 289,000,000 264,000,000
Change in Working Capital -1,719,000,000 -535,000,000 423,000,000
Operating Cash Flow 5,808,000,000 8,061,000,000 8,399,000,000
Investing Activities
Capital Expenditure -1,256,000,000 -1,296,000,000 -1,152,000,000
Investments -1,256,000,000 -1,296,000,000 -1,152,000,000
Investing Cash Flow -5,167,000,000 -5,572,000,000 -4,560,000,000
Financing Activities
Debt Repayment 5,562,000,000 665,000,000 -1,795,000,000
Common Stock Issued/Repurchased -2,900,000,000 -2,676,000,000 -2,134,000,000
Dividends Paid -1,508,000,000 -1,395,000,000 -1,229,000,000
Financing Cash Flow 1,193,000,000 -3,349,000,000 -1,318,000,000
Summary
Free Cash Flow 4,552,000,000 6,765,000,000 7,247,000,000
Net Change in Cash 1,762,000,000 -861,000,000 2,507,000,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 5,971,000,000 5,987,000,000 5,894,000,000
Depreciation & Amortization 1,393,000,000 1,745,000,000 1,675,000,000
Stock Based Compensation 191,000,000 289,000,000 264,000,000
Change in Working Capital -1,719,000,000 -535,000,000 423,000,000
Operating Cash Flow 5,808,000,000 8,061,000,000 8,399,000,000
Investing Activities
Capital Expenditure -1,256,000,000 -1,296,000,000 -1,152,000,000
Investments -1,256,000,000 -1,296,000,000 -1,152,000,000
Investing Cash Flow -5,167,000,000 -5,572,000,000 -4,560,000,000
Financing Activities
Debt Repayment 5,562,000,000 665,000,000 -1,795,000,000
Common Stock Issued/Repurchased -2,900,000,000 -2,676,000,000 -2,134,000,000
Dividends Paid -1,508,000,000 -1,395,000,000 -1,229,000,000
Financing Cash Flow 1,193,000,000 -3,349,000,000 -1,318,000,000
Summary
Free Cash Flow 4,552,000,000 6,765,000,000 7,247,000,000
Net Change in Cash 1,762,000,000 -861,000,000 2,507,000,000